Association between interleukin 10 gene -1082 A/G polymorphism and the risk of type 2 diabetes mellitus: A meta-analysis of 4250 subjects

Cytokine

Volumn 62, Issue 2, 2013, Pages 226-231

  Yin, Yan Wei ^a   Hu, Ai Min ^a   Sun, Qian Qian ^b   Zhang, Bei Bei ^c   Liu, Hong Li ^a   Wang, Qi ^a   Zeng, Yi Hua ^a   Xu, Rui Jia ^a   Zhang, Shi Jie ^a   Shi, Long Bao ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b Jinsong Sanatorium of Beijing Air Force   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Interleukin 10; Meta analysis; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

ADENOSINE; GUANOSINE; INTERLEUKIN 10;

ALLELE; ARTICLE; CONTROLLED STUDY; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INTERLEUKIN 10 GENE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW; CASE CONTROL STUDY; ETHNIC GROUP; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84876806511     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.02.025     Document Type: Article

References (31)

1. Lin J.D., Hsia T.L., Wu C.Z., Su C.C., Ma W.Y., Hsieh A.T., et al. The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus. Metabolism 2010, 59:780-786.
2. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
3. Fernández-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24:278-301.
4. Festa A., D'Agostino R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000, 102:42-47.
5. Pickup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acutephase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
6. van Exel E., Gussekloo J., de Craen A.J., Frölich M., Bootsma-Van Der Wiel A., Westendorp R.G., et al. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. Diabetes 2002, 51:1088-1092.
7. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998, 95:9465-9470.
8. Kilpinen S., Huhtala H., Hurme M. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur Cytokine Netw 2002, 13:66-71.
9. Tsiavou A., Hatziagelaki E., Chaidaroglou A., Manginas A., Koniavitou K., Degiannis D., et al. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 2004, 24:591-599.
10. Scarpelli D., Cardellini M., Andreozzi F., Laratta E., Hribal M.L., Marini M.A., et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 2006, 55:1529-1533.
11. Babel N., Gabdrakhmanova L., Hammer M.H., Schoenemann C., Skrypnikov V., Poliak N., et al. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol 2006, 19:802-807.
12. Mtiraoui N., Ezzidi I., Kacem M., Ben Hadj Mohamed M., Chaieb M., Haj Jilani A.B., et al. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes Metab Res Rev 2009, 25:57-63.
13. Kolla V.K., Madhavi G., Pulla Reddy B., Srikanth Babu B.M., Yashovanthi J., Valluri V.L., et al. Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine 2009, 47:173-177.
14. Kung W.J., Lin C.C., Liu S.H., Chaung H.C. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol Ther 2010, 12:809-813.
15. Erdogan M., Cetinkalp S., Ozgen A.G., Saygili F., Berdeli A., Yilmaz C. Interleukin-10 (-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet Test Mol Biomarkers 2012, 16:91-94.
16. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151: p. 264-9,W64.
17. Wells GA, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. <> [accessed Oct 20, 2011]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
18. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
19. Berkey C.S., Hoaglin D.C., Mosteller F., Colditz G.A. A random-effects regression model for meta-analysis. Stat Med 1995, 14:395-411.
20. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer 1959, 22:719-748.
21. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
22. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
23. Borges A.P., Guidoni C.M., de Freitas O., Pereira L.R. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq Bras Endocrinol Metabol 2011, 55:686-691.
24. Zhang Y., Zhang J., Tian C., Xiao Y., Li X., He C., et al. The -1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: a meta-analysis. J Neurol Sci 2011, 303:133-138.
25. Brooks M.V., Leake A., Parsons C., Pham V. A review of the literature: evaluating dietary intake of Filipino Americans at risk for type 2 diabetes. Nurs Forum 2012, 47:27-33.
26. Pedersen M.L. Diabetes mellitus in Greenland. Dan Med J 2012, 59:B4386.
27. McNeely M.J., Boyko E.J. Diabetes-related comorbidities in Asian Americans: results of a national health survey. J Diabetes Complications 2005, 19:101-106.
28. Zintzaras E., Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008, 61:634-645.
29. Thompson S.G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994, 309:1351-1355.
30. Munafò M.R., Flint J. Meta-analysis of genetic association studies. Trends Genet 2004, 20:439-444.
31. O'Rourke K. An historical perspective on meta-analysis: dealing quantitatively with varying study results. J R Soc Med 2007, 100:579-582.